Showing 1 - 10 of 4,313
The pharmaceutical industry is a textbook example of a science based sector characterized by high R&D cost, uncertain and spillovers for which patent protection assures appropriability thus providing incentives for innovation. Indeed, Mansfield (1986) found that, absent patent protection, 60...
Persistent link: https://www.econbiz.de/10014216850
Persistent link: https://www.econbiz.de/10011532273
Persistent link: https://www.econbiz.de/10013461393
, protectionist regulatory frameworks, and infrastructure constraints. There is significant room for service export growth, including …
Persistent link: https://www.econbiz.de/10012129565
Persistent link: https://www.econbiz.de/10014303281
largest exporter country in the world regarding the total export volume of cinnamon, but regarding the total value of exports …
Persistent link: https://www.econbiz.de/10014230691
Trade in services is a rapidly growing phenomenon. Consequently, the question of individual countries? competitiveness in trade in services is of increasing importance. In this paper we describe patterns of competitiveness in services sectors for EU members over the period 1995 to 2005,...
Persistent link: https://www.econbiz.de/10011391869
Persistent link: https://www.econbiz.de/10012154644
Prices for pharmaceutical products over the last 10 years have skyrocketed, increasing far more rapidly than the general cost of living. This article argues there should be greater competition for the production of follow-on drugs through the strengthening of the double patenting prohibition:...
Persistent link: https://www.econbiz.de/10013002400
Persistent link: https://www.econbiz.de/10013263401